In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

Today’s animal testing differs from how it was back in the day. It’s typically done on a specific ingredient rather than a finished product, and there are often regulatory requirements based on ...

“The FDA’s animal testing requirement will be reduced, refined, or potentially replaced using a range of approaches,” the agency said, including AI-based computational models about how toxic a ...

Add Yahoo as a preferred source to see more of our stories on Google. Futuristic Technology in medical concept to finding corona virus covid 19 by using ai artificial intelligence, machine learning, ...

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...